{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:28:36Z","timestamp":1792618116038,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.isci.2024.109693","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T11:47:46Z","timestamp":1712663266000},"page":"109693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Ubiquitin-specific protease 7 inhibitors reveal a differentiated mechanism of p53-driven anti-cancer activity"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2132-312X","authenticated-orcid":false,"given":"Alan S.","family":"Futran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Amberg-Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saidi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Boyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaowu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E.","family":"Kurtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey W.","family":"Tyner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Akinsanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Madge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian K.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2024.109693_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00717","article-title":"USP7 Is a Master Regulator of Genome Stability","volume":"8","author":"Valles","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.isci.2024.109693_bib2","article-title":"USP7: Novel drug target in cancer therapy","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2024.109693_bib3","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nature07290","article-title":"The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network","volume":"455","author":"Song","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.isci.2024.109693_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1620\/tjem.239.165","article-title":"Expression of USP7 and MARCH7 is correlated with poor prognosis in epithelial ovarian cancer","volume":"239","author":"Zhang","year":"2016","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.isci.2024.109693_bib5","first-page":"1742","article-title":"Clinical significance of ubiquitin specific protease 7 (USP7) in predicting prognosis of hepatocellular carcinoma and its functional mechanisms","volume":"24","author":"Wang","year":"2018","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.isci.2024.109693_bib6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41375-020-0878-x","article-title":"Inhibition of ubiquitin-specific protease 7 sensitizes acute myeloid leukemia to chemotherapy","volume":"35","author":"Cartel","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.isci.2024.109693_bib7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nchembio.2528","article-title":"Discovery and characterization of highly potent and selective allosteric USP7 inhibitors","volume":"14","author":"Gavory","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.isci.2024.109693_bib8","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature24451","article-title":"Molecular basis of USP7 inhibition by selective small-molecule inhibitors","volume":"550","author":"Turnbull","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.isci.2024.109693_bib9","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.chembiol.2017.09.003","article-title":"Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7","volume":"24","author":"Lamberto","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.isci.2024.109693_bib10","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature737","article-title":"Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization","volume":"416","author":"Li","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.isci.2024.109693_bib11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.immuni.2013.05.018","article-title":"Stabilization of the Transcription Factor Foxp3 by the Deubiquitinase USP7 Increases Treg-Cell-Suppressive Capacity","volume":"39","author":"van Loosdregt","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2024.109693_bib12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/jcb.22998","article-title":"Usp7 and Uhrf1 control ubiquitination and stability of the maintenance DNA methyltransferase Dnmt1","volume":"112","author":"Qin","year":"2011","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.isci.2024.109693_bib13","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/nm.4180","article-title":"HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma","volume":"22","author":"Tavana","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2024.109693_bib14","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1158\/1535-7163.MCT-20-0184","article-title":"Novel, selective inhibitors of USP7 uncover multiple mechanisms of antitumor activity in\u00a0vitro and in\u00a0vivo","volume":"19","author":"Ohol","year":"2020","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.isci.2024.109693_bib15","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1038\/s41598-020-62076-x","article-title":"Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism","volume":"10","author":"Schauer","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2024.109693_bib16","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nature24006","article-title":"USP7 small-molecule inhibitors interfere with ubiquitin binding","volume":"550","author":"Kategaya","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.isci.2024.109693_bib17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrd4236","article-title":"Drugging the p53 pathway: understanding the route to clinical efficacy","volume":"13","author":"Khoo","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2024.109693_bib18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/d41573-020-00130-z","article-title":"p53 programmes plough on","volume":"19","author":"Mullard","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2024.109693_bib19","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1038\/s41375-020-0949-z","article-title":"MDM2 inhibition: an important step forward in cancer therapy","volume":"34","author":"Konopleva","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.isci.2024.109693_bib20","doi-asserted-by":"crossref","first-page":"16622","DOI":"10.1021\/acs.jmedchem.2c01444","article-title":"Discovery of Orally Bioavailable N-Benzylpiperidinol Derivatives as Potent and Selective USP7 Inhibitors with In\u00a0Vivo Antitumor Immunity Activity against Colon Cancer","volume":"65","author":"Li","year":"2022","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.isci.2024.109693_bib21","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1021\/acs.jcim.0c00120","article-title":"Combining Cloud-Based Free-Energy Calculations, Synthetically Aware Enumerations, and Goal-Directed Generative Machine Learning for Rapid Large-Scale Chemical Exploration and Optimization","volume":"60","author":"Ghanakota","year":"2020","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.isci.2024.109693_bib22","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1021\/acs.accounts.7b00083","article-title":"Advancing Drug Discovery through Enhanced Free Energy Calculations","volume":"50","author":"Abel","year":"2017","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.isci.2024.109693_bib23","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1021\/acs.jcim.2c00072","article-title":"AutoDesigner, a De Novo Design Algorithm for Rapidly Exploring Large Chemical Space for Lead Optimization: Application to the Design and Synthesis of d-Amino Acid Oxidase Inhibitors","volume":"62","author":"Bos","year":"2022","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.isci.2024.109693_bib24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ccr.2012.08.007","article-title":"A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib Resistance","volume":"22","author":"Chauhan","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2024.109693_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2020.106489","article-title":"Murine double minute 2 inhibition alone or with cytarabine in acute myeloid leukemia: Results from an idasanutlin phase 1\/1b study","volume":"100","author":"Yee","year":"2021","journal-title":"Leuk. Res."},{"key":"10.1016\/j.isci.2024.109693_bib26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1182\/blood-2019-123711","article-title":"Updated Results from the Venetoclax (Ven) in Combination with Idasanutlin (Idasa) Arm of a Phase 1b Trial in Elderly Patients (Pts) with Relapsed or Refractory (R\/R) AML Ineligible for Cytotoxic Chemotherapy","volume":"134","author":"Daver","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.isci.2024.109693_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4143\/crt.2005.37.6.319","article-title":"The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis","volume":"37","author":"Yim","year":"2005","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.isci.2024.109693_bib28","doi-asserted-by":"crossref","first-page":"e867","DOI":"10.1038\/cddis.2013.400","article-title":"USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis","volume":"4","author":"Fan","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2024.109693_bib29","article-title":"Superior anti-tumor activity of the MDM2 antagonist idasanutlin and the Bcl-2 inhibitor venetoclax in p53 wild-type acute myeloid leukemia models","volume":"9","author":"Lehmann","year":"2016","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.isci.2024.109693_bib30","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ccell.2017.11.003","article-title":"Synthetic Lethality of Combined Bcl-2 Inhibition and p53 Activation in AML: Mechanisms and Superior Antileukemic Efficacy","volume":"32","author":"Pan","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2024.109693_bib31","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2018-99-116013","article-title":"Safety, Efficacy, Pharmacokinetic (PK) and Biomarker Analyses of BCL2 Inhibitor Venetoclax (Ven) Plus MDM2 Inhibitor Idasanutlin (idasa) in Patients (pts) with Relapsed or Refractory (R\/R) AML: A Phase Ib, Non-Randomized, Open-Label Study","volume":"132","author":"Daver","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.isci.2024.109693_bib32","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1182\/blood-2014-10-604975","article-title":"Inhibition of Mcl-1 with the pan-Bcl-2 family inhibitor (-)BI97D6 overcomes ABT-737 resistance in acute myeloid leukemia","volume":"126","author":"Pan","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.isci.2024.109693_bib33","first-page":"1023","article-title":"Macrophage inhibitory cytokine-1: a novel biomarker for p53 pathway activation","volume":"2","author":"Yang","year":"2003","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.isci.2024.109693_bib34","doi-asserted-by":"crossref","first-page":"11250","DOI":"10.1073\/pnas.210171597","article-title":"Generation of oscillations by the p53-Mdm2 feedback loop: A theoretical and experimental study","volume":"97","author":"Lev Bar-Or","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2024.109693_bib35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/ng1293","article-title":"Dynamics of the p53-Mdm2 feedback loop in individual cells","volume":"36","author":"Lahav","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2024.109693_bib36","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/msb.2011.20","article-title":"Stimulus-dependent dynamics of p53 in single cells","volume":"7","author":"Batchelor","year":"2011","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.isci.2024.109693_bib37","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.1218351","article-title":"p53 Dynamics Control Cell Fate","volume":"336","author":"Purvis","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.isci.2024.109693_bib38","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1200\/EDBK_279129","article-title":"The Changing Landscape of Treatment in Acute Myeloid Leukemia","volume":"40","author":"Koenig","year":"2020","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.isci.2024.109693_bib39","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/gcc.22796","article-title":"The role of TP53 in acute myeloid leukemia: Challenges and opportunities","volume":"58","author":"Barbosa","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.isci.2024.109693_bib40","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","article-title":"Functional genomic landscape of acute myeloid leukaemia","volume":"562","author":"Tyner","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.isci.2024.109693_bib41","doi-asserted-by":"crossref","first-page":"E7554","DOI":"10.1073\/pnas.1703094114","article-title":"Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies","volume":"114","author":"Kurtz","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2024.109693_bib42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1158\/0008-5472.CAN-12-1906","article-title":"Kinase pathway dependence in primary human leukemias determined by rapid inhibitor screening","volume":"73","author":"Tyner","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2024.109693_bib43","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1021\/acsmedchemlett.7b00512","article-title":"Identification and Structure-Guided Development of Pyrimidinone Based USP7 Inhibitors","volume":"9","author":"O\u2019Dowd","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.isci.2024.109693_bib44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1107\/S2059798317017235","article-title":"DIALS: implementation and evaluation of a new integration package","volume":"74","author":"Winter","year":"2018","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.isci.2024.109693_bib45","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1107\/S0907444913000061","article-title":"How good are my data and what is the resolution?","volume":"69","author":"Evans","year":"2013","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.isci.2024.109693_bib46","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.isci.2024.109693_bib47","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1107\/S0907444911001314","article-title":"REFMAC5 for the refinement of macromolecular crystal structures","volume":"67","author":"Murshudov","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.isci.2024.109693_bib48","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1107\/S0907444912017453","article-title":"Significant reduction in errors associated with nonbonded contacts in protein crystal structures: automated all-atom refinement with PrimeX","volume":"68","author":"Bell","year":"2012","journal-title":"Acta Crystallogr. D"},{"key":"10.1016\/j.isci.2024.109693_bib49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzym. Regul."},{"key":"10.1016\/j.isci.2024.109693_bib50","doi-asserted-by":"crossref","first-page":"W488","DOI":"10.1093\/nar\/gkaa216","article-title":"SynergyFinder 2.0: visual analytics of multi-drug combination synergies","volume":"48","author":"Ianevski","year":"2020","journal-title":"Nucleic Acids Res."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224009155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224009155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:32:25Z","timestamp":1783474345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004224009155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2589004224009155"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2024.109693","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ubiquitin-specific protease 7 inhibitors reveal a differentiated mechanism of p53-driven anti-cancer activity","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2024.109693","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109693"}}